医薬品開発業務受託機関サービス市場：タイプ別、調査フェーズ別、治療領域別、分子タイプ別、エンドユーザー別-2024-2030年世界予測

医薬品開発業務受託機関サービス市場規模は2023年に887億8,000万米ドルと推計され、2024年には982億8,000万米ドル、CAGR 10.98％で2030年には1,842億1,000万米ドルに達すると予測されます。

医薬品開発業務受託機関（CRO）サービスには、医薬品開発、臨床試験管理、市販後調査のために製薬、バイオテクノロジー、医療機器業界に提供されるさまざまな外部委託サポートオプションが含まれます。これらの組織は、薬事申請ガイダンス、臨床業務、データ管理、統計分析、メディカルライティング、および医療製品の上市に向けた複雑なプロセスをナビゲートするために必要なその他の機能の専門知識を提供します。CROサービスの世界の普及は、主に医薬品開発コストの高騰、複雑化する治療領域における専門知識の必要性、広範な臨床試験データと文書化を必要とする規制圧力の高まりによってもたらされています。しかし、データのセキュリティや知的財産の管理に関する潜在的な問題は、CROの採用に影響を及ぼしています。これらの懸念に対処するためには、守秘義務、知的財産権、ガバナンス構造について明確な契約合意を確立することが不可欠です。細胞治療や遺伝子治療のような先進的な治療法の台頭は、精密医療の成長とともに、CROが専門的なサービスを開発する大きな機会をもたらしています。デジタルの領域では、データ分析に人工知能や機械学習を採用し、バーチャル臨床試験を取り入れることで、新たな展開が期待される動向です。

タイプ臨床試験の複雑さと期間を管理する臨床研究サービスの採用

臨床研究サービスには、新薬、デバイス、治療プロトコルを試験し、ヒトにおける安全性と有効性を判断するための臨床試験の管理と実施が含まれます。サービスには、臨床試験のデザイン、患者の募集、規制当局への申請、実施施設の選定、モニタリング、データ収集・分析などが含まれます。CROによるコンサルティングサービスには、医薬品開発の道筋、薬事コンプライアンス、市場参入戦略に関する戦略的アドバイスが含まれ、業務改善や財務計画にも及ぶ。データマネジメントサービスには、臨床試験中に収集されたデータの収集、クリーニング、分析が含まれます。これには、電子データ収集（EDC）、生物統計学、臨床データ管理システム（CDMS）などの先端技術の利用が含まれます。早期開発サービスは、創薬から第I相および第IIA相試験までの医薬品開発の初期段階に重点を置いています。これには、医薬品化学、前臨床試験、薬物動態学、ファースト・イン・ヒト試験が含まれます。これらのサービスは、分子を研究室から臨床試験に移行させる際に専門的な知識を必要とする企業にとって、特に重要です。ラボ・サービスとは、バイオ分析サービス、臨床試験用の中央ラボ・サービス、バイオマーカー研究など、医薬品開発プロセスをサポートするために実施される様々な試験や分析を指します。

試験段階：実データと市販後サポートに強いCROの必要性

i相試験は、ヒトを対象とした試験の最初の段階であり、主に医薬品の安全性、忍容性、薬物動態、薬力学の評価に重点を置く。この段階でのサービスには、ファースト・イン・ヒューマン（FIH）試験のデザインと実施、健康ボランティア試験、初期段階の患者試験などが含まれます。第Ⅱ相試験では、患者の募集と登録戦略、概念実証試験、規制当局へのサポートと申請など、医薬品の有効性を決定し、安全性をさらに評価することに焦点が移る。第III相試験では、薬剤の有効性を確認し、副作用を監視し、標準的な治療法または同等の治療法と比較するための大規模な試験が行われ、多くの場合、多国間で実施されます。医薬品が承認され上市されると、市販後調査とも呼ばれる第IV相試験が開始され、医薬品の長期的な有効性と患者のQOLへの影響をモニタリングします。ここでの主なサービスには、リスク管理およびファーマコビジランス、長期的効果を評価するためのレジストリ研究、市場参入および償還支援が含まれます。

治療領域：がん領域の医薬品開発ではCROサービスが一貫して選好されている

心血管疾患（CVD）は依然として世界の死亡の主因であり、高血圧、心不全、不整脈などの疾患の治療開発に焦点を当てた包括的な研究サービスの必要性を促しています。CVD分野のCROサービスには、臨床試験管理、患者募集、規制当局のサポートが含まれることが多いです。皮膚科分野は、乾癬から黒色腫に至る皮膚疾患の有病率の上昇により、ますます注目を集めています。この分野で必要とされるサービスは、主に皮膚科学的エンドポイントに特化した臨床試験デザイン、患者報告アウトカム、生物統計学などです。消化器（GI）疾患には、過敏性腸症候群、クローン病、大腸がんなど幅広い疾患が含まれ、GI試験を専門とするCROの専門知識が必要とされます。多くの消化器疾患は慢性疾患であり、長期的な治療が必要であるため、このようなサービスに対する需要は旺盛です。血液関連疾患の研究である血液学では、白血病、リンパ腫、血友病などの複雑な臨床試験をナビゲートする専門CROサービスが求められています。これらのサービスは、治療レジメンの強化や根治療法の開発を目指す動きが強まる中、需要が高まっています。関節リウマチやループスなどの免疫疾患は、慢性的な進行が特徴であり、免疫調節治療に精通したサービスを必要としています。この分野では、疾患に特化した試験デザインとエンドポイントが強く求められています。新興病原体の絶え間ない脅威と抗生物質耐性の発達に伴い、感染症領域におけるCROサービスに対するニーズが高まっています。これらのサービスには、ワクチン開発、抗菌薬耐性試験、HIV、結核、肝炎などの疾患の治療試験が含まれます。アルツハイマー病、多発性硬化症、パーキンソン病などの神経疾患は、その複雑さと臨床転帰の測定が困難であることから、独特の課題を抱えています。神経画像や神経認知評価など、この複雑さを克服できるCROサービスは需要が高いです。がん領域は、がんの攻撃的な性質と革新的な治療法の継続的な必要性から、CROサービスに対する需要が持続的に高い、最もダイナミックなセグメントの一つです。サービスは早期発見から後期臨床試験まで幅広く、個別化医療や免疫腫瘍学への注目度が高まっています。

エンドユーザー：学術研究機関による強力な基礎研究能力へのニーズ

学術研究機関は多くの場合、内部インフラにかかるオーバーヘッド費用をかけずに研究を強化し、専門的なスキルセットを利用するためにCROサービスを利用しています。彼らの希望は一般的に、初期段階の研究、教育リソース、助成金ベースの資金調達に合致しています。医療機器企業は、医療機器の開発、試験、商業化に重点を置いています。CROとのパートナーシップは、厳しい規制状況を乗り切り、多相試験を管理する上で不可欠です。製薬会社やバイオテクノロジー企業は、前臨床試験から後期臨床試験、市販後調査に至るまで、研究開発サービス全般を幅広く必要としているため、CROの主要顧客となっています。

地域別インサイト

南北アメリカ、特に米国では、製薬・バイオテクノロジーセクターの充実、厳格なFDA規制、一貫した医薬品開発の重視により、CROサービスに対する需要が高いです。このため、高度なインフラ、複雑な臨床試験に関する専門知識、エンドツーエンドのサービス提供を備えた熟練CROが集中しています。APAC地域は、費用対効果の高い運営、大規模で多様な患者集団、規制環境の改善により、CROサービスの好適な目的地として急速に台頭しています。この地域では、中国やインドなどの国々が臨床試験活動のホットスポットとなっており、現地 CROが急増しています。APACのCROは、ボリューム主導のサービスに重点を置いているかもしれないが、世界レベルで競争するために、品質と技術的進歩への投資を増やしています。欧州は、製薬研究の豊かな歴史、重要な規制の枠組み、高度に熟練した労働力を背景に強力な地位を維持しており、洗練され、厳格なコンプライアンス基準を遵守するCRO活動を誘致しています。中東とアフリカは、CROサービスという点ではまだ発展途上ではあるが、ヘルスケア投資の拡大と未開拓の多様な遺伝子プールを背景に、ビジネスチャンスを提供しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医薬品開発業務受託機関サービス市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医薬品開発業務受託機関サービス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.医薬品開発業務受託機関サービス市場の市場規模および予測は？

2.医薬品開発業務受託機関サービス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.医薬品開発業務受託機関サービス市場の技術動向と規制枠組みは？

4.医薬品開発業務受託機関サービス市場における主要ベンダーの市場シェアは？

5.医薬品開発業務受託機関サービス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品研究開発への投資の増加
    • 生物製剤と核医学の普及拡大
    • 調査活動におけるアウトソーシングサービスの導入増加
  • 抑制要因
    • データ管理と整合性に関する懸念
  • 機会
    • CROによるデジタル化とアジャイルな製造・調査開発技術の導入
    • より高度な細胞・遺伝子治療のための新しい臨床試験設計とプロトコルに重点を置く
  • 課題
    • 臨床調査における患者の募集と維持の問題
• 市場セグメンテーション分析
  • タイプ：臨床試験の複雑さと期間を管理するための臨床調査サービスの導入
  • 試験段階：リアルワールドデータと市販後サポートに優れた能力を持つCROの必要性
  • 治療領域：腫瘍学の医薬品開発活動におけるCROサービスの一貫した優先
  • エンドユーザー：学術機関や調査機関による強力な基礎調査能力の必要性
• 市場動向分析
  • 医薬品研究開発に対する政府の多大な支援と、南北アメリカ全土における腫瘍学を専門とするCROの存在
  • 強力な医薬品製造能力と戦略的パートナーシップおよび買収により、アジア太平洋地域におけるCROの地理的範囲を拡大します。
  • 医薬品研究開発費の増加、複雑な規制環境、EMEA地域全体でのパートナーシップの拡大
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 医薬品開発業務受託機関サービス市場：タイプ別

• 臨床調査サービス
• コンサルティングサービス
• データ管理サービス
• 初期段階の開発サービス
• ラボサービス

第7章 医薬品開発業務受託機関サービス市場トライアルフェーズ別

• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第8章 医薬品開発業務受託機関サービス市場治療領域別

• 循環器疾患
• 皮膚科
• 胃腸
• 泌尿器と女性の健康
• 血液学
• 免疫疾患
• 感染症
• 代謝疾患/内分泌学
• 神経学
• 腫瘍学
• 眼科
• 精神医学
• 呼吸器疾患

第9章 医薬品開発業務受託機関サービス市場分子タイプ別

• 細胞および遺伝子治療疾患
• ワクチン

第10章 医薬品開発業務受託機関サービス市場：エンドユーザー別

• 学術機関
• 医療機器企業
• 製薬・バイオテクノロジー企業

第11章 南北アメリカの医薬品開発業務受託機関サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の医薬品開発業務受託機関サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの医薬品開発業務受託機関サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ヴィーダ・クリニカル・調査、欧州CROの戦略的買収で世界プレゼンスを強化、
  • EUROAPIとSpiroChemの革新的な提携により、医薬品開発におけるCRO-CDMO統合が革新的に進化
  • マリドーズ、大麻ベースの医薬品開発のための革新的なCROグループを設立
  • ジュリアス・クリニカル・調査、アンパーサンド・キャピタル・パートナーズから成長投資を受ける
  • エベレスト・クリニカル・調査、オーガスト・調査の買収を発表
  • PRC ClinicalとTrialHubが提携し、臨床試験の効率と患者募集を向上
  • オルガナバイオ、分散型臨床試験をサポートする革新的な細胞処理および凍結保存サービスを開始
  • MedRhythmsが慢性脳卒中の分散型臨床試験の契約調査機関（CRO）としてCuravitを選択
  • 世界中の臨床試験とあらゆる治療法との戦略的パートナーシップを通じてヘルスケアを革新する
  • ClinChoice、CROMSOURCEの戦略的買収により世界展開を拡大
  • アバニアがマクシスを買収：医療技術の開発と商業化を強化
  • TFSヘルスサイエンス、アップルツリーCIグループの買収で視野を広げる

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 98. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 99. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 100. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 101. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 104. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 105. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 106. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 107. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 108. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 109. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 110. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 111. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 112. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 113. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 114. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 115. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 116. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 117. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 120. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 121. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 124. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 125. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 126. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 127. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 128. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 129. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 130. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 131. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 132. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 133. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 134. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 135. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 136. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 137. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 142. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 143. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 144. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 145. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 146. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 147. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 148. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 149. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 150. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 151. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 152. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 153. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 154. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 155. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 156. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 157. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 160. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 161. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 162. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 163. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 164. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 165. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 166. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 167. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 168. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 169. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 170. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 171. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 172. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 173. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 178. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 179. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 180. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 181. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 182. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 183. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 184. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 185. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 186. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 187. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 188. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 189. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 190. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 191. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 196. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 197. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 198. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 199. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 200. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 201. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 202. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 203. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 204. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 205. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 206. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 207. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 208. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 209. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 212. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 213. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 214. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 215. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 216. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 217. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 218. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 219. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 220. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 221. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 222. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 223. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 224. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 225. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 226. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 227. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 228. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 229. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 230. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 231. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 232. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 233. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 234. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 235. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 236. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 237. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 238. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 239. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 240. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 241. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 242. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 243. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 244. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 245. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 246. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 247. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 248. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 249. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 254. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 255. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
• TABLE 256. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
• TABLE 257. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
• TABLE 258. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
• TABLE 259. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 260. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 261. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
• TABLE 262. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
• TABLE 263. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 264. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 265. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
• TABLE 266. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
• TABLE 267. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 270. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 271. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
• TABLE 272. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
• TABLE 273. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-

[188 Pages Report] The Contract Research Organization Services Market size was estimated at USD 88.78 billion in 2023 and expected to reach USD 98.28 billion in 2024, at a CAGR 10.98% to reach USD 184.21 billion by 2030.

Contract research organization (CRO) services encompass a range of outsourced support options provided to pharmaceutical, biotechnology, and medical device industries for drug development, clinical trial management, and post-marketing surveillance. These organizations offer expertise in regulatory submission guidance, clinical operations, data management, statistical analysis, medical writing, and other functions necessary to navigate the complex processes of bringing a medical product to market. The global proliferation of CRO services is mainly driven by the escalating costs of drug development, the need for specialized knowledge in increasingly complex therapeutic areas, and mounting regulatory pressures that require extensive clinical trial data and documentation. However, potential issues with data security and management of intellectual property impact their adoption. Establishing clear contractual agreements delineating confidentiality obligations, IP rights, and governance structures is essential to address these concerns. The rise of advanced therapies like cell and gene therapies, along with the growth of precision medicine, presents a substantial opportunity for CROs to develop specialized services. In the digital realm, the employment of artificial intelligence and machine learning for data analysis and the incorporation of virtual clinical trials are trends expected to offer new avenues for expansion.

Type: Adoption of clinical research services to manage the complexity and duration of clinical trials

Clinical research services involve the management and execution of clinical trials to test new drugs, devices, and treatment protocols to determine their safety and efficacy in humans. Services include trial design, patient recruitment, regulatory submissions, site selection, monitoring, and data collection and analysis. Consulting services by CROs involve strategic advice on drug development pathways, regulatory compliance, and market entry strategies, and they also extend to operational improvements and financial planning. Data management services encompass the collection, cleaning, and analysis of data gathered during clinical trials. This includes the use of advanced technologies such as electronic data capture (EDC), biostatistics, and clinical data management systems (CDMS). Early phase development services are focused on the initial stages of drug development, from drug discovery through Phase I and Phase IIA studies. This includes medicinal chemistry, preclinical studies, pharmacokinetics, and first-in-human trials. These services are particularly relevant for companies that require specialized expertise in transitioning a molecule from the lab to clinical testing. Laboratory services refer to a range of tests and analyses conducted in support of the drug development process, including bioanalytical services, central lab services for clinical trials, and biomarker studies.

Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support

Phase I trials are the first stage of testing in human subjects and primarily focus on assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. Services in this phase include first-in-human (FIH) trial design and execution, healthy volunteer studies, and early-stage patient trials, among others. In Phase II, the focus shifts towards determining the efficacy of the drug and further evaluating its safety, including patient recruitment and enrollment strategies, proof-of-concept studies, and regulatory support and filings. Phase III trials involve large-scale studies, often multinational, to confirm the drug's efficacy, monitor side effects, and compare it with standard or equivalent treatments. Once a drug is approved and marketed, Phase IV studies, also known as post-marketing surveillance, are initiated to monitor the drug's long-term effectiveness and impact on the patient's quality of life. Key services here include risk management and pharmacovigilance, registry studies to assess long-term effects, and market access and reimbursement support.

Therapeutic Area: Consistent preference for CRO services in oncology drug development activities

Cardiovascular diseases (CVD) remain a major cause of mortality globally, driving the need for comprehensive research services focusing on the development of treatments for conditions such as hypertension, heart failure, and arrhythmias. CRO services for CVD often include clinical trial management, patient recruitment, and regulatory support. The dermatology sector is increasingly attracting attention due to the rising prevalence of skin disorders ranging from psoriasis to melanoma. Services required in this area predominantly encompass clinical trial design specific to dermatological endpoints, patient-reported outcomes, and biostatistics. Gastrointestinal (GI) disorders include a wide range of conditions, such as irritable bowel syndrome, Crohn's disease, and colorectal cancer, requiring the expertise of CROs specialized in GI studies. Demand for such services is strong due to the chronic nature of many GI diseases and the necessity for long-term treatment regimens. Hematology, the study of blood-related diseases, demands specialized CRO services to navigate complex clinical trials for conditions like leukemia, lymphoma, and hemophilia. These services are in high demand as the quest to enhance treatment regimens and develop curative therapies intensifies. Immunological disorders, such as rheumatoid arthritis and lupus, are marked by chronic progression and require services that are adept at handling immune-modulating treatments. This segment reveals a strong preference for disease-specific trial designs and endpoints. With the continuous threat of emerging pathogens and the development of antibiotic resistance, there is a substantial need for CRO services within infectious diseases. These services include vaccine development, antimicrobial resistance studies, and treatment trials for diseases, including HIV, tuberculosis, and hepatitis. Neurological conditions, such as Alzheimer's disease, multiple sclerosis, and Parkinson's disease, pose unique challenges due to their complexity and the difficulty in measuring clinical outcomes. CRO services that can navigate this complexity, including neuroimaging and neurocognitive assessments, are in high demand. Oncology is one of the most dynamic segments with a persistently high demand for CRO services due to the aggressive nature of cancer and the ongoing need for innovative therapies. Services span early-stage discovery to late-stage clinical trials, with an increasing focus on personalized medicine and immuno-oncology.

End-User: Need for strong foundational research capabilities by academic and research institutions

Academic Institutes often engage CRO services to bolster research without the overhead costs of internal infrastructure and to access specialized skill sets. Their preferences are generally aligned with early-phase research, educational resources, and grant-based funding integration. Medical device companies focus on the development, testing, and commercialization of medical devices. CRO partnerships are vital in navigating the stringent regulatory landscape and managing multi-phase trials. Pharmaceutical and Biotechnology firms are the primary clients for CROs due to their extensive need for full-spectrum research and development services ranging from preclinical studies to late-stage clinical trials and post-marketing surveillance.

Regional Insights

In the Americas, particularly the United States, there is a high demand for CRO services owing to a substantial pharmaceutical and biotechnology sector, stringent FDA regulations, and a consistent emphasis on drug development. This results in a concentration of seasoned CROs equipped with advanced infrastructure, expertise in complex clinical trials, and end-to-end service offerings. The APAC region is rapidly emerging as a favorable destination for CRO services, owing to its cost-effective operations, large and diverse patient population, and improving regulatory environment. This region has seen a surge in local CROs, with countries such as China and India becoming hotspots for clinical trial activities. APAC's CROs may focus on volume-driven services but are increasingly investing in quality and technological advancements to compete on a global level. Europe maintains a strong position with a rich history of pharmaceutical research, a key regulatory framework, and a highly skilled workforce, attracting CRO activities that are sophisticated and adhere to strict compliance standards. The Middle East and Africa, though still nascent in terms of CRO services, offer opportunities due to growing healthcare investments and untapped diverse genetic pools.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contract Research Organization Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contract Research Organization Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contract Research Organization Services Market, highlighting leading vendors and their innovative profiles. These include AccuLab Life Sciences, ACTIVA-CRO, Advanced Clinical Research Services, LLC, BioAgile Therapeutics Pvt. Ltd., Caidya, Calian Group Ltd., Celerion, Inc., Charles River Laboratories International, Inc., Clinical Trial Service B.V. by PCM Trials, Cromsource by ClinChoice, CTI Clinical Trial & Consulting, Distefar del Sur SL, Ergomed PLC, Firma Clinical Research, LLC, Frontage Holdings Corporation, Geistek Pharma S.L., HCL Technologies Limited, Icon PLC, INQUIS, IQVIA Holdings Inc., KCR S.A., Laboratory Corporation of America Holdings, Leon Research, S.L., Linical Co., Ltd., Medpace Holdings, Inc., Novotech Health Holdings, OPIS S.r.l., Oxon Epidemiology, S.L., Parexel International Corporation, Pepgra, Pharmaron Beijing Co., Ltd., Pivotal, S.L.U., PPD Inc. by Thermo Fisher Scientific Inc., Prometrika, LLC, ProRelix Services LLP, PSI CRO AG, QualitecFarma S.L., SGS S.A., Syncro Clinical Research SRL, Syneos Health, Inc., The Emmes Company, LLC, Veeda Clinical Research Limited, Vial Health Technology, Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co., Ltd., and X7 Research.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Clinical Research Services
  • Consulting Services
  • Data Management Services
  • Early Phase Development Services
    • Chemistry, Manufacturing & Control
    • Discovery Studies
    • Preclinical Services
      • Pharmacokinetics/Pharmacodynamics
      • Toxicology Testing
  • Laboratory Services
    • Analytical Testing
      • Batch Release Testing
      • Physical Characterization
      • Raw Material Testing
      • Stability Testing

• Bioanalytical Testing
• Trial Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

• Therapeutic Area
  • Cardiovascular Disease
  • Dermatology
  • Gastrointestinal
  • Genitourinary & Women's Health
  • Hematology
  • Immunological Disorders
  • Infectious Diseases
  • Metabolic Disorders/Endocrinology
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory Disorders

• Molecule Type
  • Cell & Gene Therapy Diseases
  • Vaccines

• End-User
  • Academic Institutes
  • Medical Device Companies
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contract Research Organization Services Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contract Research Organization Services Market?

3. What are the technology trends and regulatory frameworks in the Contract Research Organization Services Market?

4. What is the market share of the leading vendors in the Contract Research Organization Services Market?

5. Which modes and strategic moves are suitable for entering the Contract Research Organization Services Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing investments in pharmaceutical research and development
    • 5.1.1.2. Growing penetration of biologics and nuclear medicines
    • 5.1.1.3. Rise in adoption of outsourced services for research activities
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with data management and integrity
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of digitized and agile manufacturing and research development techniques by CROs
    • 5.1.3.2. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
  • 5.1.4. Challenges
    • 5.1.4.1. Issues of patient recruitment and retention for clinical research
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Adoption of clinical research services to manage the complexity and duration of clinical trials
  • 5.2.2. Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support
  • 5.2.3. Therapeutic Area: Consistent preference for CRO services in oncology drug development activities
  • 5.2.4. End-User: Need for strong foundational research capabilities by academic and research institutions
• 5.3. Market Trend Analysis
  • 5.3.1. Substantial government support for pharmaceutical R&D, along with the presence of CROs specializing in oncology across the Americas
  • 5.3.2. Robust pharmaceutical manufacturing capabilities and strategic partnerships and acquisitions to expand the geographical footprint of CROs in the APAC region
  • 5.3.3. Increased pharmaceutical R&D expenditure, complex regulatory environments, and expanding partnerships across the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Contract Research Organization Services Market, by Type

• 6.1. Introduction
• 6.2. Clinical Research Services
• 6.3. Consulting Services
• 6.4. Data Management Services
• 6.5. Early Phase Development Services
• 6.6. Laboratory Services

7. Contract Research Organization Services Market, by Trial Phase

• 7.1. Introduction
• 7.2. Phase I
• 7.3. Phase II
• 7.4. Phase III
• 7.5. Phase IV

8. Contract Research Organization Services Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular Disease
• 8.3. Dermatology
• 8.4. Gastrointestinal
• 8.5. Genitourinary & Women's Health
• 8.6. Hematology
• 8.7. Immunological Disorders
• 8.8. Infectious Diseases
• 8.9. Metabolic Disorders/Endocrinology
• 8.10. Neurology
• 8.11. Oncology
• 8.12. Ophthalmology
• 8.13. Psychiatry
• 8.14. Respiratory Disorders

9. Contract Research Organization Services Market, by Molecule Type

• 9.1. Introduction
• 9.2. Cell & Gene Therapy Diseases
• 9.3. Vaccines

10. Contract Research Organization Services Market, by End-User

• 10.1. Introduction
• 10.2. Academic Institutes
• 10.3. Medical Device Companies
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Contract Research Organization Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Contract Research Organization Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Contract Research Organization Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Veeda Clinical Research Bolsters Global Presence with Strategic Acquisition of European CRO, Heads
  • 14.3.2. Innovative Partnership between EUROAPI and SpiroChem Revolutionizes CRO-CDMO Integration for Drug Development
  • 14.3.3. Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
  • 14.3.4. Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
  • 14.3.5. Everest Clinical Research Announces the Acquisition of August Research
  • 14.3.6. PRC Clinical and TrialHub Unite to Elevate Clinical Trial Efficiency and Patient Recruitment
  • 14.3.7. OrganaBio Launches Innovative Cell Processing and Cryopreservation Services to Support Decentralized Clinical Trials
  • 14.3.8. MedRhythms Choses Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial
  • 14.3.9. Innovating Healthcare through a Strategic Partnership between Worldwide Clinical Trials and Every Cure
  • 14.3.10. ClinChoice Expands Global Reach with Strategic Acquisition of CROMSOURCE
  • 14.3.11. Avania Acquires MAXIS: Enhancing Medtech Development and Commercialization
  • 14.3.12. TFS HealthScience Broadens Its Horizons with Appletree CI Group Acquisition

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio